Using Near-Infrared Light to Better Understand Peripheral Artery Disease
A legfontosabb adatok
- Ki végzi
- The University of Texas at Arlington
- Hol
- Arlington (Egyesült Államok)Mind a 2 helyszín megnézése
- Azonosító
- Állapot
- Toboroz
- Résztvevők
- 120 fő, tervezett
- Kezdés
- 2025. nov. 1.
- Várható befejezés
- 2028. dec. 31.
- A vizsgálat típusa
- Megfigyeléses, 2 csoport
- A regiszteradat frissítve
- 2026. január 2.
Ki vehet részt
MI-összefoglaló
A vizsgálat saját részvételi feltételeiből. Gép olvasta ki az oldalon álló regiszterszövegből, ezért tévedhet. Hogy ki vehet részt, azt a lenti regiszterszöveg és a vizsgálat csapata dönti el.
The trial is looking for adults with peripheral artery disease (narrowed leg arteries) confirmed by a doctor. It is also looking for healthy people without this disease as a comparison group.
- Életkor
- 18 years or older.
- Nem
- All sexes can join.
- A betegség stádiuma
- Patients: peripheral artery disease confirmed by a doctor, with an Ankle-Brachial Index between 0.4 and 0.9. Healthy volunteers: no symptoms and no history of the disease.
- Korábbi kezelés
- For the second part, patients must have completed the first part of the study.
- Biomarker vagy leletérték
- Ankle-Brachial Index (a blood pressure test comparing ankle and arm) not above 0.9 and not below 0.4.
A részvétel fő kizáró okai
- Unstable chest pain (angina) or heart attack in the past 12 months.
- Reasons you cannot have an MRI scan, such as a pacemaker, cochlear implant, permanent jewelry, pregnancy, or continuous oxygen therapy.
- Not able to walk 10 feet, or physical limits that prevent the tests.
- Patients: disease only in the aorta or iliac (pelvic) arteries.
- Healthy volunteers: heart or lung disease (mild asthma allowed), current tobacco use, or blood pressure above 150/90 mmHg.
A regiszter feltételei, szó szerint
Mind a 6 feltétel megnézéseKevesebb
Ki vehet részt
- Cases, Aim 1; 18 or older; willing to participate under the conditions described in the informed consent form (ICF); eligible to sign the ICF; established diagnosis of PAD confirmed by a physician; able to comply with the study requirements
- Cases, Aim 2; completed Aim 1
- Controls 1) asymptomatic, with no history or diagnosis of peripheral artery disease
Ki nem vehet részt
- Cases, Aim 1; Ankle-Brachial Index >0.9 or <0.4; isolated disease in aorta/iliac vessels; unstable angina or myocardial infarction in past 12 months; orthopedic or other physical limitations which would prevent data collection; contraindications to MRI, including presence of a Pacemaker, presence of bone growth/ bone fusion stimulators, presence of tissue expander, presence of cochlear implants, unable to ambulate for 10 feet, receiving continuous Oxygen therapy, pregnancy, permanent Jewelry (screened using MRI safety screening form and verbal screening by MRI operator
- Cases, Aim 2; unstable angina or myocardial infarction in past 12 months; orthopedic or other physical limitations which would prevent data collection; contraindications to MRI, including presence of a pacemaker, presence of bone growth/ bone fusion stimulators, presence of tissue expander, presence of cochlear implants, unable to ambulate for 10 feet, receiving continuous Oxygen therapy, pregnancy, permanent Jewelry (screened using MRI safety screening form and verbal screening by MRI operator)
- Controls 1) history of peripheral artery disease 2) overt cardiovascular disease (e.g. heart failure) 3) known pulmonary disease (excluding mild asthma) 4) current tobacco use 5) orthopedic or other physical limitations which would prevent data collection, 6) BP >150/90 mmHg at screening 7) contraindications to MRI, including presence of a pacemaker, presence of bone growth/ bone fusion stimulators, presence of tissue expander, presence of cochlear implants, unable to ambulate for 10 feet, receiving continuous Oxygen therapy, pregnancy, permanent Jewelry (screened using MRI safety screening form and verbal screening by MRI operator)
Ez a vizsgálat jelenleg itt érhető el: Egyesült Államok.
- University of Texas ArlingtonArlington, Egyesült ÁllamokContact: Rajvi Shah, MPHToborzás még nem indult
- University of Texas at ArlingtonArlington, Egyesült ÁllamokContact: Rajvi ShahRésztvevőt keres
A vizsgálatról
Mit akar kideríteni a vizsgálat
The goal of this study is to better understand how blood flows and how oxygen is utilized in the lower limbs of people who suffer from peripheral artery disease. This study will also assess how these factors affect treatment outcomes.
A teljes eredeti leírásKevesebb
Specific aims include:
Aim 1: Utilize BB-NIR-DCS to differentiate PAD patients experiencing primary oxygen delivery limitations from those suffering from mitochondrial dysfunction.
Aim 2: Test the efficacy of BB-NIR-DCS at predicting individual responses to vascular intervention.
A vizsgálat 2 csoportja
- Healthy Controls
Individuals without PAD
- Cases with PAD
Individuals with PAD
Kérdések a vizsgálat csapatának
- Milyen gyakran kell bejárnom, és egy-egy alkalom mennyi ideig tart?
- Megtérítik az utazási költséget?
- Megtarthatom a saját orvosomat?
- Mi történik, ha ki akarok lépni?
Contact the study team: see the registry record → Contacts and Locations
Oldal nyomtatása az orvosomnakAdatok és források
- Regiszteradat
- Szerepel a ClinicalTrials.gov-on.
- Hivatalos cím
- Near-Infrared Diffuse Correlation Spectroscopy to Better Define the Pathophysiology of Peripheral Artery Disease
- MI-összefoglaló
- A vizsgálat saját részvételi feltételeiből. Gépi kiolvasás: 2026. november 14.
- A regiszteradat frissítve
- 2026. január 2.